Journal Article

Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment

Ophthalmology Retina (2022) 6(11) 1105-1106
DOI: 10.1016/j.oret.2022.05.021
3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Author supplied keywords

Cite

CITATION STYLE

APA

Al-khersan, H., Patel, N. A., Yannuzzi, N. A., Lin, J., & Smiddy, W. E. (2022). Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment. Ophthalmology Retina, 6(11), 1105–1106. https://doi.org/10.1016/j.oret.2022.05.021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free